Medbright Ai Invts Inc.
MBAIF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | -0.00 | 0.07 | -0.61 |
| FCF Yield | -11.56% | -89.87% | -62.02% | -206.97% |
| EV / EBITDA | 5.88 | -0.18 | -5.77 | 0.25 |
| Quality | ||||
| ROIC | 29.92% | -24.42% | -68.69% | -150.73% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 57.30% |
| Cash Conversion Ratio | -0.84 | 0.23 | 2.97 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | 5.40% |
| Free Cash Flow Growth | 65.80% | -29.42% | 75.54% | -51.32% |
| Safety | ||||
| Net Debt / EBITDA | 0.13 | 1.10 | -0.55 | -0.18 |
| Interest Coverage | 0.00 | -34.24 | -5.56 | -28.96 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 37.23 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 1.13 |